CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients and Consumers interested in managing their heart health. It is the first company to receive Canadian and American medical device clearances to sell its hand held HeartCheck ECG monitors directly to consumers (OTC). As new wearable and medical devices are brought to market, CardioComm Solutions will seek opportunities to integrate these hardware technologies with its software and to its customer and distributor base. Products are sold worldwide through a combination of an external distribution networks. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada.